Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Klinikum der Goethe Universität Frankfurt

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaB-cell Acute Lymphoblastic Leukemia
Similarity Score30%

Elias Jabbour, MD

M.D. Anderson Cancer Center

Moderately Similar
15 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaB-cell Acute Lymphoblastic Leukemia
Similarity Score30%

xiaowen tang, Ph.D

The First Affiliated Hospital of Soochow University

Moderately Similar
11 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic LeukemiaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score30%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Partow Kebriaei, MD

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01207388Phase 2PrincipalInvestigator

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

B-cell Acute Lymphoblastic Leukemia
Completed
NCT01466179Phase 2PrincipalInvestigator

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia
Completed

All 2 trials loaded